This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
White LK, Wright WE, Shay JW . Telomerase inhibitors. Trends Biotechnol 2001; 19: 114–120.
Hiyama E, Hiyama K . Telomerase as tumor marker. Cancer Lett 2003; 194: 221–233.
Adamson DJ, King DJ, Haites NE . Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 1992; 61: 204–206.
Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 1998; 12: 13–24.
Franco S, Ozkaynak MF, Sandoval C, Tugal O, Jayabose S, Engelhardt M et al. Telomere dynamics in childhood leukemia and solid tumors: a follow-up study. Leukemia 2003; 17: 401–410.
Malaska J, Sklenickova M, Krejci K, Fajkusova L, Bajer M, Hrstkova H et al. Telomerase activity and expression and telomere analysis in situ in the course of treatment of childhood leukemias. Blood Cells Mol Dis 2000; 26: 534–539.
Verstovsek S, Manshouri T, Smith FO, Giles FJ, Cortes J, Estey E et al. Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia. Cancer 2003; 97: 2212–2217.
Januszkiewicz D, Wysoki J, Lewandowski K, Pernak M, Nowicka K, Rembowska J et al. Lack of correlation between telomere length and telomerase activity and expression in leukemic cells. Int J Mol Med 2003; 12: 935–938.
Ohyashiki JH, Ohyashiki K, Iwama H, Hayashi S, Toyama K, Shay JW . Clinical implications of telomerase activity levels in acute leukemia. Clin Cancer Res 1997; 3: 619–625.
Schroeder H, Garwicz S, Kristinsson J, Siimes MA, Wesenberg F, Gustafsson G . Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediatr Oncol 1995; 25: 372–378.
Kleideiter E, Schwab M, Friedrich U, Koscielniak E, Schäfer BW, Klotz U . Telomerase activity in cell lines of pediatric soft tissue sarcomas. Pediatr Res 2003; 54: 718–723.
Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE et al. Loss of Smad3 in acute T-cell lymphoblastic leukaemia. N Engl J Med 2004; 351: 552–559.
Acknowledgements
This work was supported by the Robert Bosch Foundation, Stuttgart, Germany, the Reinhold Beitlich Foundation, Tübingen, Germany, and in part by a EU Grant (MOL CANCER MED to PB). We thank Dagmar Weller, Katja Simon-Klingenstein and Hermann Stammer for their excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kleideiter, E., Bangerter, U., Schwab, M. et al. Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL). Leukemia 19, 296–298 (2005). https://doi.org/10.1038/sj.leu.2403596
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403596